BioCardia Announces FDA Completes Review of Proposed Adaptive Statistical Analysis Design for Ongoing CardiAMP Cell Therapy in Heart Failure Pivotal Study
June 20, 2023 17:14 ET
|
BioCardia, Inc.
SUNNYVALE, Calif., June 20, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary...
New to The Street Signs Acurx Pharmaceuticals, Inc. to Additional Six-Month Media Contract with Iconic Billboard Ads and Commercial Support
March 23, 2023 16:00 ET
|
FMW Media Works Corp
NEW YORK, March 23, 2023 (GLOBE NEWSWIRE) -- FMW Media's business TV show, New to The Street, announces signing Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ($ACXP) ("Acurx") to an additional...
Gravity Branding names Novartis’ Vijoice® (alpelisib)
August 08, 2022 15:59 ET
|
Gravity Branding
SAN FRANCISCO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Gravity Branding, the agency behind naming blockbuster drugs including Novartis’ Kisqali® (ribociclib), Genentech’s Herceptin® (trastuzumab) and...
LAVA Therapeutics Receives FDA Orphan Drug Designation for LAVA-051 for the Treatment of Chronic Lymphocytic Leukemia
October 15, 2021 07:00 ET
|
Lava Therapeutics N.V.
UTRECHT, The Netherlands and PHILADELPHIA, Oct. 15, 2021 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (Nasdaq: LVTX), a clinical-stage biotechnology company, today announced that the U.S. Food and...
Acadia Pharmaceuticals, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm
June 14, 2021 09:00 ET
|
Portnoy Law
Investors with losses of over $100,000 are encouraged to contact the firm before June 18, 2021; click here to submit trade information LOS ANGELES, June 14, 2021 (GLOBE NEWSWIRE) -- The Portnoy...
SAFE PRINT 360 - DEFENDER AGAINST BACTERIA
March 10, 2021 15:07 ET
|
Flottman Company
Cincinnati, Ohio - Northern Kentucky, March 10, 2021 (GLOBE NEWSWIRE) -- Introducing Safe Print 360, Flottman Company’s new antimicrobial substrate coating, formulated to inhibit 99% of bacterial...